Asparagine Synthetase Deficiency causes reduced proliferation of cells under conditions of limited asparagine.

Mol Genet Metab 2015 Nov 14;116(3):178-86. Epub 2015 Aug 14.

Sydney Children's Hospital, High Street Randwick NSW 2031, Australia; University of New South Wales, High Street, Sydney, NSW 2052, Australia; Seals Molecular Genetics, POW Hospital Campus, Barker Street, Randwick, Sydney, NSW 2031, Australia. Electronic address:

Asparagine Synthetase Deficiency is a recently described cause of profound intellectual disability, marked progressive cerebral atrophy and variable seizure disorder. To date there has been limited functional data explaining the underlying pathophysiology. We report a new case with compound heterozygous mutations in the ASNS gene (NM_183356.3:c. [866G>C]; [1010C>T]). Both variants alter evolutionarily conserved amino acids and were predicted to be pathogenic based on in silico protein modelling that suggests disruption of the critical ATP binding site of the ASNS enzyme. In patient fibroblasts, ASNS expression as well as protein and mRNA stability are not affected by these variants. However, there is markedly reduced proliferation of patient fibroblasts when cultured in asparagine-limited growth medium, compared to parental and wild type fibroblasts. Restricting asparagine replicates the physiology within the blood-brain-barrier, with limited transfer of dietary derived asparagine, resulting in reliance of neuronal cells on intracellular asparagine synthesis by the ASNS enzyme. These functional studies offer insight into the underlying pathophysiology of the dramatic progressive cerebral atrophy associated with Asparagine Synthetase Deficiency.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10967192153004
Publisher Site
http://dx.doi.org/10.1016/j.ymgme.2015.08.007DOI Listing
November 2015
46 Reads

Publication Analysis

Top Keywords

synthetase deficiency
12
asparagine synthetase
12
underlying pathophysiology
8
reduced proliferation
8
cerebral atrophy
8
progressive cerebral
8
patient fibroblasts
8
asns enzyme
8
asparagine
7
expression well
4
asns expression
4
enzyme patient
4
fibroblasts asns
4
well protein
4
mrna stability
4
proliferation patient
4
fibroblasts cultured
4
markedly reduced
4
variants markedly
4
stability variants
4

Similar Publications